Skip to main content

Advertisement

Log in

MicroRNA-183 promotes migration and invasion of CD133+/CD326+ lung adenocarcinoma initiating cells via PTPN4 inhibition

  • Original Article
  • Published:
Tumor Biology

Abstract

Non-small cell lung cancer (NSCLC) is the most common cancer worldwide and is a leading cause of lung cancer mortality due to early stage metastases. Cancer stem-like cells (CSLCs) or tumor-initiating cells (TICs) are rare subpopulation cells that are responsible for maintaining tumor growth and invasion leading to recurrence and metastasis. Previous studies revealed that miR-183 can mediate the invasiveness and growth of NSCLC. However, the exact role of miR-183 in regulating the biological behavior of CSLCs in NSCLC remains unclear. In the present study, we explored the regulation of protein tyrosine phosphatase non-receptor type 4 (PTPN4) by miR-183 in vitro using luciferase reporter assays, and we further analyzed the effects of miR-183 on the invasiveness of CSLCs in vitro and in vivo using transwell and bioluminescence assays. Following our finding that miR-183 binds to PTPN4 messenger RNA (mRNA) to prevent its translation through the 3′-untranslated region (UTR), we found that overexpression of miR-183 in CSLCs decreased PTPN4 protein levels while inhibition of miR-183 increased PTPN4 protein levels. The suppression of PTPN4 levels in CSLCs by miR-183 paralleled with a significant promotion in their motility in vitro and in vivo, while anti-sense miR-183 increased PTPN4 levels in CSLCs, which paralleled with a significant decrease in their invasiveness. Furthermore, correlation analysis between miR-183 and PTPN4 in clinical samples demonstrated a statistically significant inverse correlation between PTPN4 mRNA levels and miR-183. In brief, our data indicate that miR-183 plays a pro-invasive role by inverse regulation of PTPN4, and this axis may be a new therapeutic target for suppressing the metastatic capability of CSLCs in NSCLC.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Long HX, Xiang T, Qi W, Huang J, Chen J, He L, et al. CD133+ ovarian cancer stem-like cells promote non-stem cancer cell metastasis via CCL5 induced epithelial-mesenchymal transition. Oncotarget. 2015;6(8):5846–59.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Roberto GC, Chitralekha B, Nandita G, Lisa B, Per B, Michael G, et al. Non-small cell lung cancer cells survived ionizing radiation treatment display cancer stem cell and epithelial-mesenchymal transition phenotypes. Mol Cancer. 2013;12(2):390–7.

    Google Scholar 

  3. Yang L, Ping YF, Yu X, Qian F, Guo ZJ, Qian C, et al. Gastric cancer stem-like cells possess higher capability of invasion and metastasis in association with a mesenchymal transition phenotype. Cancer Lett. 2011;310(1):46–52.

    CAS  PubMed  Google Scholar 

  4. Hiraga T, Ito S, Nakamura H. Cancer stem-like cell marker CD44 promotes bone metastases by enhancing tumorigenicity, cell motility, and hyaluronan production. Cancer Res. 2013;73(13):4112–22.

    Article  CAS  PubMed  Google Scholar 

  5. Vira D, Basak SK, Veena MS, Wang MB, Batra RK, Srivatsan ES. Cancer stem cells, microRNAs, and therapeutic strategies including natural products. Cancer Metastasis Rev. 2012;31(3-4):733–51.

    Article  CAS  PubMed  Google Scholar 

  6. Ji J, Yamashita T, Budhu A, Forgues M, Jia HL, Li C, et al. Identification of microRNA-181 by genome-wide screening as a critical player in EpCAM-positive hepatic cancer stem cells. Hepatology. 2009;50(2):472–80.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Ma C, Huang T, Ding YC, Yu W, Wang Q, Meng B, et al. microRNA-200c overexpression inhibits chemoresistance, invasion and colony formation of human pancreatic cancer stem cells. Int J Clin Exp Pathol. 2015;8(6):6533–9.

    PubMed  PubMed Central  Google Scholar 

  8. Daisuke Y, Toru K, Shiro O, Hisaaki T, Madoka I, Ryo M, et al. Mir340 suppresses the stem-like cell function of glioma-initiating cells by targeting tissue plasminogen activator. Cancer Res. 2015;75(6):1123–33.

    Article  Google Scholar 

  9. Nandy SB, Arumugam A, Subramani R, Pedroza D, Hernandez K, Saltzstein E, et al. Microrna-125a influences breast cancer stem cells by targeting leukemia inhibitory factor receptor which regulates the hippo signaling pathway. Oncotarget. 2015;6(19):17366–78.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Liu T, Qin W, Hou L, Huang Y. Microrna-17 promotes normal ovarian cancer cells to cancer stem cells development via suppression of the LKB1-p53-p21/WAF1 pathway. Tumour Biol. 2014;36(3):1881–93.

    Article  PubMed  Google Scholar 

  11. Hwang WL, Jiang JK, Yang SH, Huang TS, Lan HY, Teng HW, et al. MicroRNA-146a directs the symmetric division of snail-dominant colorectal cancer stem cells. Nat Cell Biol. 2014;16(3):268–80.

    Article  CAS  PubMed  Google Scholar 

  12. Hsieh IS, Chang KC, Tsai YT, Ke JY, Lu PJ, Lee KH, et al. Microrna-320 suppresses the stem cell-like characteristics of prostate cancer cells by downregulating the Wnt/beta-catenin signaling pathway. Carcinogenesis. 2013;34(3):530–8.

    Article  CAS  PubMed  Google Scholar 

  13. Lin S, Sun JG, Wu JB, Long HX, Zhu CH, Xiang T, et al. Aberrant microRNAs expression in CD133+/CD326+ human lung adenocarcinoma initiating cells from A549. Mol Cells. 2012;33(3):277–83.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Huai W, Song H, Wang L, Li B, Zhao J, Han L, et al. Phosphatase PTPN4 preferentially inhibits TRIF-dependent TLR4 pathway by dephosphorylating tram. J Immunol. 2015;194(9):4458–65.

    Article  CAS  PubMed  Google Scholar 

  15. Zhou J, Wang BB, Shan JX, Shi HL, Li YH, Huo KK. PTPN4 negatively regulates CRKI in human cell lines. Cell Mol Biol Lett. 2013;18(2):297–314.

    Article  CAS  PubMed  Google Scholar 

  16. Douglas RH, Mick DE, Gray KS, Christopher C, Benz KSV, Danny RW. Breast cancer metastasis suppressor1 up-regulates miR-146, which suppresses breast cancer metastasis. Cancer Res. 2009;69(4):1279–83.

    Article  Google Scholar 

  17. Saver AL, Li LH, Subramanian S. MicroRNA miR-183 functions as an oncogene by targeting the transcription factor EGR1 and promoting tumor cell migration. Cancer Res. 2010;70(23):9570–80.

    Article  Google Scholar 

  18. Gu W, Gao T, Shen J, Sun Y, Zheng X, Wang J, et al. MicroRNA-183 inhibits apoptosis and promotes proliferation and invasion of gastric cancer cells by targeting PDCD4. Int J Clin Exp Med. 2014;7(9):2519–29.

    CAS  PubMed  PubMed Central  Google Scholar 

  19. Ren LH, Chen WX, Li S, He XY, Zhang ZM, Li M, et al. MicroRNA-183 promotes proliferation and invasion in oesophageal squamous cell carcinoma by targeting programmed cell death 4. Br J Cancer. 2014;111(10):2003–13.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Qiu M, Liu L, Chen L, Tan G, Liang Z, Wang K, et al. microRNA-183 plays as oncogenes by increasing cell proliferation, migration and invasion via targeting protein phosphatase 2A in renal cancer cells. Biochem. Biophys. Res. Compt Rendus Geosci. 2014;452(1):163–9.

    CAS  Google Scholar 

  21. Wang GF, Mao WM, Zheng S. MicroRNA-183 regulates Ezrin expression in lung cancer cells. FEBS Lett. 2008;582(25-26):3663–8.

    Article  CAS  PubMed  Google Scholar 

  22. Wellner U, Schubert J, Burk UC, Schmalhofer O, Zhu F, Sonntag A, et al. The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs. Nat Cell Biol. 2009;11(2):1487–95.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

This work was supported by the National Natural Science Foundation of China (NSFC81201682).

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Zhengtang Chen or Sheng Lin.

Ethics declarations

The care and use of mice was performed in accordance with ethical guidelines of Southwest Medical University.

Additional information

Conghui Zhu and Xi Deng contributed equally to this work.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zhu, C., Deng, X., Wu, J. et al. MicroRNA-183 promotes migration and invasion of CD133+/CD326+ lung adenocarcinoma initiating cells via PTPN4 inhibition. Tumor Biol. 37, 11289–11297 (2016). https://doi.org/10.1007/s13277-016-4955-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13277-016-4955-8

Keywords

Navigation